Thus, the block of the STX biosynthesis process has proposed as an alternative anti-virulence therapy, in which crtM and crtN are target for drugs used in the treatment of infections caused by pigmented S. aureus (Wang et al., 2016). The gene discussed is MATN1; the disease is infection.